Tisch MS News

Tisch MSRCNY research scientist Dr. Roberto Alfonso, and his recent research paper around COVID-19 vaccines, were featured in an article in Managed Healthcare Executive. In the piece, Dr. Alfonso highlights the significance of the research findings, which suggest that MS patients receiving anti-...

September 7, 2022

More

Tisch MSRCNY research scientist Dr. Roberto Alfonso has been featured on an episode of Real Talk MS podcast about our recent research paper around COVID-19 vaccines, on which he was the lead author and which was published in the journal Frontiers in Immunology . This study’s findings – which showed...

August 31, 2022

More

The Tisch MSRCNY – and our recent research around the potential causes of sporadic ALS (sALS), using our novel animal model – have been featured in an article in ALS News Today. Based on our research, which was recently published in Brain Communications , this piece in ALS News Today highlights the...

August 31, 2022

More

The Larry G. Gluck Division of ALS Research located at the Tisch MS Research Center of New York has published research in Brain Communications . In this study, Tisch researchers developed a first-of-its-kind cerebrospinal fluid-mediated mouse model to identify apolipoprotein B-100 (ApoB) as a key...

August 22, 2022

More

The paper shows that MS patients receiving anti-CD20 therapy saw strong T-cell activation in response to receiving the COVID-19 vaccination, even in conditions of deficient antibody production. Furthermore, our research found no difference in patients’ T-cell response regardless of form of the...

August 8, 2022

More

Join us in congratulating Rose for her outstanding performance as the Best Junior Scientist!

August 3, 2022

More

Last week our researchers and physicians discussed a paper about the identification of anti-oligodendrocyte antibodies and their implications in MSdisease pathology. MSis an autoimmune disease characterized by damage to the Central Nervous System (CNS), specifically to myelin sheaths and...

July 27, 2022

More

Tisch MSRCNY and Dr. Violaine Harris have been featured in an article in Managed Healthcare Executive about the preliminary analysis of results from our FDA-approved stem cell treatment study. The Q&A highlights the impact of our stem cell research, in particular the potential of our biomarker...

July 13, 2022

More

During the interview, Dr. Sadiq discusses the preliminary analysis of results from our FDA-approved stem cell treatment study and the exciting implications they could have for MS treatment moving forward. He also gives listeners further background on our center and some of the other groundbreaking...

June 29, 2022

More

Tisch MSRCNY, and our FDA-approved stem cell treatment study, have been featured in an article in BioSpace. Drawing from interviews with Dr. Sadiq and Dr. Harris, this piece highlights the great progress that our stem cell treatment research has seen so far, and the tremendous impact we expect the...

June 8, 2022

More

Pages

News Archive

Pages

Tisch MS Research Center of New York

521 West 57th Street
4th Floor
New York, NY 10019
(646) 557-3900

Privacy Policy

 

Support Tisch MS

Support Tisch MS and our innovative research leading to treatments that improve the lives of patients.